NCT06783985Completed
Clinical Application of Carbon Nanoparticles in Lymph Node Tracing and Surgery Guiding of Colorectal Cancer
Source: ClinicalTrials.gov · Last updated 20 Jan 2025
Brief summary (registry, in English)
This trial aims to clarify the relationship between carbon nanoparticles labeled lymph nodes and lymph node metastasis in different lymph node regions of colorectal cancer, and to clarify the application value of carbon nanoparticles in lymph node dissection in colorectal cancer surgery.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 146 (actual)
- First submitted
- 8 Jan 2025
- Start date
- 16 Mar 2022
- Primary completion date
- 20 Apr 2024
- Lead sponsor
- Sir Run Run Shaw Hospital
- Diseases
- Colorectal cancer
- NCT number
- NCT06783985
What you commit to
- Study type: Observational
- Participants enrolled: 146
- From 16 Mar 2022 to the primary completion date, 20 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- (a) emergency surgery;
Who the study is looking for
- a diagnosis of colorectal cancer;
- endoscopic injection of CNP suspension preoperatively
- planned radical resection of colorectal cancer
- older than 18 years of age
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sir Run Run Shaw Hospital Coordinator of this site? Confirm its status | Hangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.